Thierry Chauche
CIK 1895174 · Chief Financial Officer · last filed 2026-06-01
Thierry Chauche is a Chief Financial Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for SGMT, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$7.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $386.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$386.8K
2
9
-$7.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGMT | Chief Financial Officer | 59,688 | $6.48 | $386.8K | -$7.0K | 5 | 2026-06-01 |
| Provention Bio, Inc. (PRVB) Delisted | Chief Financial Officer | — | $24.98 | — | $0 | 4 | 2023-04-27 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | SGMT | Grant (A) | — | $0 | EDGAR |
| 2026-02-20 | SGMT | Grant (A) | +44,000 | $0 | EDGAR |
| 2026-02-12 | SGMT | Sell (S) | −1,312 | -$7.0K | EDGAR |
| 2025-02-07 | SGMT | Grant (A) | +17,000 | $0 | EDGAR |
| 2024-05-08 | SGMT | Grant (A) | — | $0 | EDGAR |
| 2023-04-27 | Provention Bio, Inc. (PRVB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-01-11 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-20 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-01 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |